These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29344328)

  • 61. Adherence to an acotiamide therapeutic regimen improves long-term outcomes in patients with functional dyspepsia.
    Shinozaki S; Osawa H; Sakamoto H; Hayashi Y; Miura Y; Lefor AK; Yamamoto H
    J Gastrointestin Liver Dis; 2017 Dec; 26(4):345-350. PubMed ID: 29253047
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia--a multicenter, double-blind, randomized, placebo-controlled study.
    Suzuki H; Matsuzaki J; Fukushima Y; Suzaki F; Kasugai K; Nishizawa T; Naito Y; Hayakawa T; Kamiya T; Andoh T; Yoshida H; Tokura Y; Nagata H; Kobayakawa M; Mori M; Kato K; Hosoda H; Takebayashi T; Miura S; Uemura N; Joh T; Hibi T; Tack J;
    Neurogastroenterol Motil; 2014 Jul; 26(7):950-61. PubMed ID: 24766295
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gastric Activity and Gut Peptides in Patients With Functional Dyspepsia: Postprandial Distress Syndrome Versus Epigastric Pain Syndrome.
    Russo F; Chimienti G; Clemente C; Riezzo G; D'Attoma B; Martulli M
    J Clin Gastroenterol; 2017 Feb; 51(2):136-144. PubMed ID: 27092429
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
    Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH
    Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Management of gastroparesis and functional dyspepsia after cisapride withdrawal].
    Louis H
    Rev Med Brux; 2012 Sep; 33(4):425-9. PubMed ID: 23091951
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Application of the Rome IV Criteria to Functional Esophagogastroduodenal Disorders in Asia.
    Suzuki H
    J Neurogastroenterol Motil; 2017 Jul; 23(3):325-333. PubMed ID: 28672431
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Timing and Predictors of Recurrence of Dyspepsia Symptoms after Cessation of Acotiamide Therapy for Functional Dyspepsia: A Long-Term Observational Study.
    Shinozaki S; Osawa H; Sakamoto H; Hayashi Y; Kobayashi Y; Miura Y; Lefor AK; Yamamoto H
    Digestion; 2020; 101(4):382-390. PubMed ID: 31063995
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sleep disorders in functional dyspepsia and future therapy.
    Futagami S; Shimpuku M; Yamawaki H; Izumi N; Kodaka Y; Nagoya H; Wakabayashi T; Shindo T; Kawagoe T; Sakamoto C
    J Nippon Med Sch; 2013; 80(2):104-9. PubMed ID: 23657063
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A case of advanced systemic sclerosis with severe GERD successfully treated with acotiamide.
    Kato R; Nakajima K; Takahashi T; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Takiguchi S; Mori M; Doki Y
    Surg Case Rep; 2016 Dec; 2(1):36. PubMed ID: 27072944
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New developments in the treatment of gastroparesis and functional dyspepsia.
    Tack J; Camilleri M
    Curr Opin Pharmacol; 2018 Dec; 43():111-117. PubMed ID: 30245474
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of acotiamide on gastric emptying in healthy adult humans.
    Zai H; Matsueda K; Kusano M; Urita Y; Saito Y; Kato H
    Eur J Clin Invest; 2014 Dec; 44(12):1215-21. PubMed ID: 25370953
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats.
    Seto K; Sasaki T; Katsunuma K; Kobayashi N; Tanaka K; Tack J
    Neurogastroenterol Motil; 2008 Sep; 20(9):1051-9. PubMed ID: 18482254
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Functional dyspepsia and the Rome criteria: a success story.
    Talley NJ
    Neurogastroenterol Motil; 2015 Aug; 27(8):1052-6. PubMed ID: 26220646
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evidence-based clinical practice guidelines for functional dyspepsia 2021.
    Miwa H; Nagahara A; Asakawa A; Arai M; Oshima T; Kasugai K; Kamada K; Suzuki H; Tanaka F; Tominaga K; Futagami S; Hojo M; Mihara H; Higuchi K; Kusano M; Arisawa T; Kato M; Joh T; Mochida S; Enomoto N; Shimosegawa T; Koike K
    J Gastroenterol; 2022 Feb; 57(2):47-61. PubMed ID: 35061057
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Associations between gastric sensorimotor function, depression, somatization, and symptom-based subgroups in functional gastroduodenal disorders: are all symptoms equal?
    Clauwaert N; Jones MP; Holvoet L; Vandenberghe J; Vos R; Tack J; Van Oudenhove L
    Neurogastroenterol Motil; 2012 Dec; 24(12):1088-e565. PubMed ID: 22816492
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Functional dyspepsia: new insights into pathogenesis and therapy.
    Talley NJ
    Korean J Intern Med; 2016 May; 31(3):444-56. PubMed ID: 27048251
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Extensive gastric mucosal atrophy is a possible predictor of clinical effectiveness of acotiamide in patients with functional dyspepsia
.
    Miki A; Yamamoto T; Maruyama K; Nakamura N; Aoyagi H; Isono A; Abe K; Kita H
    Int J Clin Pharmacol Ther; 2017 Dec; 55(12):901-904. PubMed ID: 29092728
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Efficacy and Safety of New Prokinetic Agent Benachio Q Solution® in Patients with Postprandial Distress Syndrome Subtype in Functional Dyspepsia: A Single-center, Randomized, Double-blind, Placebo-controlled Pilot Study].
    Shim YK; Lee JY; Kim NY; Park YH; Yoon H; Shin CM; Park YS; Lee DH
    Korean J Gastroenterol; 2015 Jul; 66(1):17-26. PubMed ID: 26194125
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.
    Futagami S; Shimpuku M; Song JM; Kodaka Y; Yamawaki H; Nagoya H; Shindo T; Kawagoe T; Horie A; Gudis K; Iwakiri K; Sakamoto C
    Digestion; 2012; 86(2):114-21. PubMed ID: 22846371
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Causes and treatment of functional dyspepsia.
    Tack J; Bisschops R; DeMarchi B
    Curr Gastroenterol Rep; 2001 Dec; 3(6):503-8. PubMed ID: 11696288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.